Could a common drug stop Alzheimer's before it starts?
NCT ID NCT05063851
First seen Jan 20, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study tests whether memantine, a drug already used for Alzheimer's symptoms, can help prevent the disease in people at high risk. It includes 32 adults aged 50 to 65 who have a family history of dementia and carry the ApoE4 gene. The main goal is to see if it's practical to run a larger prevention trial, not yet to prove the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Virginia
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.